Davenport & Co’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$490K Sell
20,142
-75
-0.4% -$1.83K ﹤0.01% 860
2025
Q1
$420K Buy
20,217
+838
+4% +$17.4K ﹤0.01% 872
2024
Q4
$456K Buy
19,379
+150
+0.8% +$3.53K ﹤0.01% 851
2024
Q3
$492K Sell
19,229
-1,591
-8% -$40.7K ﹤0.01% 808
2024
Q2
$489K Buy
20,820
+173
+0.8% +$4.06K ﹤0.01% 786
2024
Q1
$594K Buy
20,647
+1,018
+5% +$29.3K ﹤0.01% 736
2023
Q4
$644K Buy
19,629
+200
+1% +$6.56K ﹤0.01% 678
2023
Q3
$541K Buy
19,429
+38
+0.2% +$1.06K ﹤0.01% 688
2023
Q2
$661K Sell
19,391
-60
-0.3% -$2.05K ﹤0.01% 657
2023
Q1
$585K Sell
19,451
-18
-0.1% -$541 ﹤0.01% 662
2022
Q4
$550K Sell
19,469
-1,076
-5% -$30.4K ﹤0.01% 643
2022
Q3
$675K Sell
20,545
-92
-0.4% -$3.02K 0.01% 579
2022
Q2
$650K Sell
20,637
-117
-0.6% -$3.69K 0.01% 595
2022
Q1
$953K Sell
20,754
-1,332
-6% -$61.2K 0.01% 548
2021
Q4
$1.35M Sell
22,086
-91
-0.4% -$5.58K 0.01% 480
2021
Q3
$1.66M Buy
22,177
+614
+3% +$45.9K 0.01% 426
2021
Q2
$2M Sell
21,563
-723
-3% -$66.9K 0.02% 333
2021
Q1
$1.98M Sell
22,286
-2,421
-10% -$215K 0.02% 283
2020
Q4
$2.3M Buy
24,707
+87
+0.4% +$8.11K 0.02% 256
2020
Q3
$1.57M Sell
24,620
-678
-3% -$43.2K 0.02% 272
2020
Q2
$1.32M Buy
25,298
+1,558
+7% +$81.3K 0.02% 288
2020
Q1
$743K Buy
23,740
+6,200
+35% +$194K 0.01% 340
2019
Q4
$588K Buy
17,540
+4,030
+30% +$135K 0.01% 439
2019
Q3
$466K Sell
13,510
-600
-4% -$20.7K 0.01% 460
2019
Q2
$486K Buy
14,110
+3,185
+29% +$110K 0.01% 450
2019
Q1
$359K Buy
10,925
+1,250
+13% +$41.1K ﹤0.01% 500
2018
Q4
$232K Buy
9,675
+1,200
+14% +$28.8K ﹤0.01% 563
2018
Q3
$283K Buy
8,475
+1,075
+15% +$35.9K ﹤0.01% 568
2018
Q2
$215K Buy
+7,400
New +$215K ﹤0.01% 632